Structures by: Prasad D. J.
Total: 19
C20H23NO2S2
C20H23NO2S2
Organic & Biomolecular Chemistry (2009) 7, 24 5091-5097
a=7.6290(15)Å b=11.646(2)Å c=11.722(2)Å
α=115.05(3)° β=92.13(3)° γ=92.44(3)°
C18H19NO2S2
C18H19NO2S2
Organic & Biomolecular Chemistry (2009) 7, 24 5091-5097
a=13.5039(4)Å b=12.3329(3)Å c=10.3136(3)Å
α=90.00° β=95.7070(10)° γ=90.00°
C19H21NO2S2
C19H21NO2S2
Organic & Biomolecular Chemistry (2009) 7, 24 5091-5097
a=14.6365(4)Å b=12.8539(3)Å c=9.8406(3)Å
α=90.00° β=97.7590(10)° γ=90.00°
C21H25NO2S2
C21H25NO2S2
Organic & Biomolecular Chemistry (2009) 7, 24 5091-5097
a=8.2666(3)Å b=13.1054(4)Å c=18.5231(7)Å
α=90.00° β=95.842(2)° γ=90.00°
3-(4-methylphenyl)-5-[4-(methylthio)phenyl]-4, 5-dihydro-1H-pyrazole-1-carbaldehyde
C18H18N2OS
Acta Crystallographica Section E (2007) 63, 10 o4005-o4006
a=6.3751(17)Å b=6.9998(17)Å c=19.791(5)Å
α=83.57(2)° β=81.70(2)° γ=64.16(2)°
2-Methyl-6-(trifluoromethyl)imidazo[1,2-<i>a</i>]pyridine-3-carbonitrile
C10H6F3N3
Acta Crystallographica Section E (2011) 67, 3 o573
a=5.6871(3)Å b=8.5437(5)Å c=20.5403(13)Å
α=90.00° β=96.653(4)° γ=90.00°
2-Isobutyl-6-(4-methoxyphenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C15H17N3OS
Acta Crystallographica Section E (2011) 67, 2 o255
a=5.71390(10)Å b=10.17950(10)Å c=12.9689(2)Å
α=85.1740(10)° β=85.1640(10)° γ=80.6900(10)°
(<i>E</i>)-3-(4-Chlorophenyl)-1-(2,3,4-trichlorophenyl)prop-2-en-1-one
C15H8Cl4O
Acta Crystallographica Section E (2011) 67, 2 o241
a=3.8879(2)Å b=6.7510(3)Å c=13.7788(5)Å
α=97.620(2)° β=96.177(2)° γ=92.017(2)°
2-Isobutyl-6-phenylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C14H15N3S
Acta Crystallographica Section E (2011) 67, 2 o254
a=5.69210(10)Å b=19.6453(4)Å c=12.3610(2)Å
α=90.00° β=96.1270(10)° γ=90.00°
2-[4-(Methylsulfonyl)phenyl]acetonitrile
C9H9NO2S
Acta Crystallographica Section E (2011) 67, 3 o574
a=5.5599(2)Å b=8.0942(3)Å c=10.9006(4)Å
α=81.162(2)° β=85.347(2)° γ=74.458(2)°
6-(4-Chlorophenyl)-2-isobutylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C14H14ClN3S
Acta Crystallographica Section E (2011) 67, 1 o207
a=5.75520(10)Å b=26.4052(5)Å c=9.7662(2)Å
α=90.00° β=101.3880(10)° γ=90.00°
Methyl 2-[2-(benzyloxycarbonylamino)propan-2-yl]-5-hydroxy-6-methoxypyrimidine-4-carboxylate
C18H21N3O6
Acta Crystallographica Section E (2011) 67, 2 o274
a=16.5226(2)Å b=8.57170(10)Å c=13.0944(2)Å
α=90.00° β=97.2360(10)° γ=90.00°
<i>N</i>'-(4-Chlorobenzylidene)-2-[4-(methylsulfanyl)phenyl]acetohydrazide
C16H15ClN2OS
Acta Crystallographica Section E (2011) 67, 11 o2847
a=17.0923(13)Å b=9.6719(7)Å c=9.5592(7)Å
α=90.00° β=92.3990(10)° γ=90.00°
(5<i>E</i>)-5-(2,4-Dichlorobenzylidene)-2-(piperidin-1-yl)- 1,3-thiazol-4(5<i>H</i>)-one
C15H14Cl2N2OS
Acta Crystallographica Section E (2011) 67, 11 o2884
a=28.5303(3)Å b=7.49150(10)Å c=15.4789(2)Å
α=90.00° β=116.4070(10)° γ=90.00°
3-{1-[4-(2-Methylpropyl)phenyl]ethyl}-4-phenyl-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C20H23N3S
Acta Crystallographica Section E (2011) 67, 8 o1943
a=6.3249(2)Å b=12.4958(5)Å c=12.9125(4)Å
α=77.6490(10)° β=78.1330(10)° γ=76.5510(10)°
(5<i>E</i>)-5-(4-Methoxybenzylidene)-2-(piperidin-1-yl)-1,3-thiazol- 4(5<i>H</i>)-one
C16H18N2O2S
Acta Crystallographica Section E (2011) 67, 8 o1915
a=8.5811(3)Å b=16.5165(6)Å c=12.4930(4)Å
α=90.00° β=121.518(2)° γ=90.00°
<i>N</i>-[(<i>E</i>)-4-Chlorobenzylidene]-2,4-dimethylaniline
C15H14ClN
Acta Crystallographica Section E (2011) 67, 8 o1932
a=7.28520(10)Å b=15.2715(2)Å c=11.53820(10)Å
α=90.00° β=96.3040(10)° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-2-({5-[4-(methylsulfanyl)benzyl]-4-phenyl-4<i>H</i>- 1,2,4-triazol-3-yl}sulfanyl)acetamide
C24H21ClN4OS2
Acta Crystallographica Section E (2011) 67, 8 o2063
a=14.2542(7)Å b=16.3273(9)Å c=10.1584(6)Å
α=90.00° β=96.3720(10)° γ=90.00°
(<i>E</i>)-1-(3,4-Dimethoxyphenyl)-3-[4-(methylsulfanyl)phenyl]prop-2-en-1-one
C18H18O3S
Acta Crystallographica Section E (2011) 67, 9 o2403
a=19.0863(7)Å b=19.0863(7)Å c=8.9633(4)Å
α=90.00° β=90.00° γ=90.00°